Zelgor 500mg Tablet is a clinically established pharmaceutical preparation containing ABIRATERONE ACETATE as its primary active ingredient. It falls under the Oncology therapeutic class and is widely prescribed for the management of associated medical conditions. The medicine exerts its action through a well-defined pharmacological mechanism, targeting specific receptors, enzymes, or biological pathways to produce the desired clinical effect. Manufactured by SUN PHARMACEUTICAL INDUSTRIES LTD, Zelgor 500mg Tablet is available in Tablet form. This medicine is classified under the Anti Cancer general category and the Oncology speciality domain, reflecting its use within this therapeutic area. Patients should note that dosage and treatment duration must be individualized based on the patient's clinical condition, age, weight, organ function, and concurrent medications.

• Primary Indication: Management and treatment of conditions in the Oncology therapeutic domain as diagnosed and confirmed by a qualified specialist. • Combination Therapy: May be used as part of a multi-drug regimen to achieve synergistic therapeutic effects. • Monotherapy: Can be prescribed as a standalone agent where single-drug therapy is appropriate. • Maintenance Therapy: Used for long-term disease control and prevention of relapse. • Second-Line Therapy: Indicated in patients who have not responded adequately to first-line treatments. • Geriatric Use: Suitable for elderly patients with dose adjustments based on renal, hepatic, and cardiovascular status under close monitoring.

Zelgor 500mg Tablet containing ABIRATERONE ACETATE exerts its therapeutic effects through a well-defined pharmacological mechanism relevant to oncology conditions. The active ingredient interacts with specific molecular targets to modulate biological pathways and produce the desired clinical effect. Therapeutically, Zelgor 500mg Tablet is classified under the Anti Cancer category and the Oncology speciality domain. Regular therapeutic monitoring is recommended to ensure optimal drug levels and evaluate treatment response.

• Always inform your doctor about every medicine you are currently taking before starting Zelgor 500mg Tablet. • CYP450 Enzyme Interactions: Medicines that inhibit or induce CYP450 enzymes may significantly increase or decrease blood levels of ABIRATERONE ACETATE. • Anticoagulants: Concurrent use may alter anticoagulant effect — monitor INR frequently. • Nephrotoxic or Hepatotoxic Agents: Avoid concurrent use unless supervised by a specialist with regular monitoring.

Zelgor 500mg Tablet is a prescription-only medicine (Schedule H / H1 or equivalent) and must not be purchased or used without a valid prescription from a licensed medical practitioner. Storage: Store below 25°C. Protect from moisture and sunlight. Disposal: Do not flush unused medicines or dispose in household waste. Return unused or expired medicines to a licensed pharmacy. Regulatory Information: Manufactured by SUN PHARMACEUTICAL INDUSTRIES LTD and complies with applicable drug regulatory standards. Pharmacovigilance: Report any unexpected, severe, or serious adverse effects to your doctor and to CDSCO in India through the online ADR reporting system.